Total Payments
$407,211
2024 Payments
$51,647
Companies
10
Transactions
224
Medicare Patients
758
Medicare Billing
$90,872
Payment Breakdown by Category
Research$179,289 (44.0%)
Other$169,755 (41.7%)
Consulting$38,807 (9.5%)
Travel$10,431 (2.6%)
Food & Beverage$8,928 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $179,289 | 4 | 44.0% |
| Honoraria | $88,880 | 35 | 21.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $80,875 | 44 | 19.9% |
| Consulting Fee | $38,807 | 22 | 9.5% |
| Travel and Lodging | $10,431 | 60 | 2.6% |
| Food and Beverage | $8,928 | 59 | 2.2% |
Payments by Type
General
$227,922
220 transactions
Research
$179,289
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurelis, Inc. | $206,865 | 34 | $0 (2023) |
| SK Life Science, Inc. | $130,047 | 120 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $34,714 | 31 | $0 (2024) |
| Greenwich Biosciences, Inc. | $21,976 | 23 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $5,074 | 6 | $0 (2017) |
| NEUROPACE, INC. | $4,398 | 6 | $0 (2024) |
| Astellas Pharma Global Development | $1,600 | 1 | $0 (2017) |
| Upsher-Smith Laboratories LLC | $1,500 | 1 | $0 (2017) |
| AQUESTIVE THERAPEUTICS, INC. | $1,020 | 1 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $15.57 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51,647 | 51 | SK Life Science, Inc. ($31,474) |
| 2023 | $30,633 | 35 | JAZZ PHARMACEUTICALS INC. ($12,263) |
| 2022 | $221,950 | 42 | Neurelis, Inc. ($181,873) |
| 2021 | $31,956 | 23 | SK Life Science, Inc. ($25,075) |
| 2020 | $49,560 | 53 | SK Life Science, Inc. ($29,740) |
| 2019 | $13,290 | 12 | Greenwich Biosciences, Inc. ($13,290) |
| 2017 | $8,174 | 8 | Sun Pharmaceutical Industries Inc. ($5,074) |
All Payment Transactions
224 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $700.00 | General |
| Category: Neurology | ||||||
| 12/10/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $140.35 | General |
| Category: Neurology | ||||||
| 11/27/2024 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $1,180.00 | General |
| 11/08/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| Category: Neurology | ||||||
| 10/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 10/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $20.64 | General |
| Category: Neurology | ||||||
| 09/26/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Epilepsy | ||||||
| 09/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Neurology | ||||||
| 09/04/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,130.00 | General |
| Category: NEUROLOGY | ||||||
| 09/03/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Travel and Lodging | In-kind items and services | $7.37 | General |
| Category: NEUROLOGY | ||||||
| 08/22/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $106.90 | General |
| Category: NEUROLOGY | ||||||
| 07/25/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | Cash or cash equivalent | $79.62 | General |
| Category: Neurology | ||||||
| 07/25/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $44.00 | General |
| Category: Neurology | ||||||
| 07/25/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $41.32 | General |
| Category: Neurology | ||||||
| 07/25/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $22.78 | General |
| Category: Neurology | ||||||
| 07/24/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Epilepsy | ||||||
| 07/18/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $5,250.00 | General |
| Category: Neurology | ||||||
| 07/18/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | In-kind items and services | $480.00 | General |
| Category: Neurology | ||||||
| 06/16/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | In-kind items and services | $223.91 | General |
| Category: Neurology | ||||||
| 05/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $2,800.00 | General |
| Category: Neurology | ||||||
| 05/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Neurology | ||||||
| 05/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $30.82 | General |
| Category: Neurology | ||||||
| 05/29/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| Category: Neurology | ||||||
| 05/29/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $121.46 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RNS VALTOCO PILOT STUDY | Neurelis, Inc. | $175,689 | 2 |
| HEOR Consultants | SK Life Science, Inc. | $3,600 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 168 | 245 | $91,076 | $20,898 |
| 2022 | 5 | 181 | 260 | $92,112 | $23,801 |
| 2021 | 6 | 202 | 281 | $86,071 | $24,268 |
| 2020 | 7 | 207 | 265 | $88,663 | $21,905 |
Total Patients
758
Total Services
1,051
Medicare Billing
$90,872
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 100 | 148 | $44,844 | $8,671 | 19.3% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 28 | 54 | $32,616 | $8,467 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 16 | $5,600 | $1,707 | 30.5% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 13 | 15 | $5,880 | $1,535 | 26.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 12 | 12 | $2,136 | $518.16 | 24.3% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 38 | 69 | $42,820 | $10,308 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 91 | 132 | $30,718 | $8,172 | 26.6% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 22 | 23 | $9,224 | $2,377 | 25.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 18 | 23 | $7,138 | $2,365 | 33.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 12 | 13 | $2,212 | $579.88 | 26.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 97 | 143 | $27,599 | $9,470 | 34.3% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 28 | 57 | $35,910 | $9,177 | 25.6% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 24 | 24 | $9,792 | $2,564 | 26.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 12 | 15 | $4,110 | $1,365 | 33.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 25 | 26 | $4,420 | $1,134 | 25.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 16 | 16 | $4,240 | $558.04 | 13.2% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 36 | 66 | $41,580 | $10,884 | 26.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 70 | 89 | $17,177 | $4,224 | 24.6% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 19 | 22 | $8,976 | $2,321 | 25.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 24 | 28 | $7,672 | $1,820 | 23.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 28 | 30 | $7,950 | $1,530 | 19.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 14 | 14 | $2,380 | $655.80 | 27.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 16 | 16 | $2,928 | $470.50 | 16.1% |
About Dr. Michael Privitera, MD
Dr. Michael Privitera, MD is a Epilepsy healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629005814.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Privitera, MD has received a total of $407,211 in payments from pharmaceutical and medical device companies, with $51,647 received in 2024. These payments were reported across 224 transactions from 10 companies. The most common payment nature is "" ($179,289).
As a Medicare-enrolled provider, Privitera has provided services to 758 Medicare beneficiaries, totaling 1,051 services with total Medicare billing of $90,872. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Epilepsy
- Other Specialties Neurology
- Location Cincinnati, OH
- Active Since 06/26/2006
- Last Updated 09/25/2024
- Taxonomy Code 2084E0001X
- Entity Type Individual
- NPI Number 1629005814
Products in Payments
- VALTOCO (Drug) $206,865
- XCOPRI (Drug) $106,404
- EPIDIOLEX (Drug) $31,784
- Cenobamate (Drug) $23,608
- Epidiolex (Drug) $21,976
- Tildra (Drug) $5,074
- RNS Neurostimulator Kit (Device) $4,398
- Xtandi (Drug) $1,600
- APTIOM (Drug) $15.57
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.